Cyclacel Pharmaceuticals' Unattributed VC Round

Cyclacel Pharmaceuticals raised a round of funding on August 23, 1998. Investors include Allianz.

Cyclacel Pharmaceuticals is a biotechnology company developing novel cell-based immunotherapeutic treatments for cancer and infectious disease.…

Articles about Cyclacel Pharmaceuticals' Unattributed VC Round: